Newsnation
@newsnation·2.7M subscribers·86.7K videos
FDA endorses experimental Alzheimer's drug for full FDA approval | NewsNation Live
Posted
June 12, 2023
Views
1,090
Likes
24
Comments
7
Engagement
June 12, 2023
1,090
24
7
2.84%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
5:20Now PlayingThe drug, Leqembi, received conditional approval from the FDA in January based on early results suggesting it could slow Alzheimer’s progression by several months. The FDA now is reviewing more definitive results to decide whether the drug should receive the agency’s full endorsement. Dr. Corey Hebert discusses the pros and cons of this medication being FDA-approved and widely used.
#FDA #Alzheimers #Legembi
Get a fast-paced look at the latest from the border to Main Street to the White House on "NewsNation Live with Marni Hughes." Weekdays starting at 10a/9C.#NewsNationLive
NewsNation is your source for fact-based, unbiased news for all America.
More from NewsNation
Get our app
Find us on cable
How to watch on TV or streaming
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
